We are live on ! Find out more
CP

Centerbridge Partners Portfolio holdings

AUM $61.1M
1-Year Est. Return 3.67%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+3.67%
3 Year Est. Return
+16.09%
5 Year Est. Return
+20.97%
10 Year Est. Return
+25.5%
AUM
$1.75B
AUM Growth
+$897M
Cap. Flow
+$847M
Cap. Flow %
48.3%
Top 10 Hldgs %
94.4%
Holding
60
New
4
Increased
3
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
GTXAP
Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock
GTXAP
+$538M
2
FUN icon
Cedar Fair
FUN
+$73.4M
3
INDT
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
+$71.2M
4
HAIAU
Healthcare AI Acquisition Corp. Unit
HAIAU
+$4.81M
5
GDS icon
GDS Holdings
GDS
+$1.65M

Top Sells

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$4.45M
2
SPAQ
Spartan Acquisition Corp. III
SPAQ
+$1.48M
3
CFV
CF Acquisition Corp. V Class A Common Stock
CFV
+$881K
4
BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
+$66.3K
5
FACA.WS
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
+$11

Sector Composition

Rank Sector Weight
1 Real Estate 14.56%
2 Healthcare 11.81%
3 Financials 11.42%
4 Consumer Discretionary 7.96%
5 Industrials 4.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHG
26
DELISTED
United Homes Group
UHG
$974K 0.06%
100,000
– –
HIII
27
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$972K 0.06%
100,000
– –
BIOT
28
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$918K 0.05%
93,250
-6,750
-7% -$66.3K
FACA
29
DELISTED
Figure Acquisition Corp. I
FACA
$490K 0.03%
50,000
– –
AAC
30
DELISTED
Ares Acquisition Corporation
AAC
$487K 0.03%
50,000
– –
EQHA
31
DELISTED
EQ Health Acquisition Corp.
EQHA
$485K 0.03%
50,000
– –
PAQC
32
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
$372K 0.02%
37,731
– –
VTIQW
33
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
$327K 0.02%
389,999
– –
LCAHW
34
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
$126K 0.01%
125,000
– –
AFAQW
35
DELISTED
AF Acquisition Corp Warrants
AFAQW
$118K 0.01%
200,000
– –
BGSX.WS
36
DELISTED
Build Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
BGSX.WS
$104K 0.01%
149,999
– –
RUMBW
37
RUM Group Inc Warrant
RUMBW
$13.2M
$98K 0.01%
37,500
– –
PRPC.WS
38
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$87K 0.01%
80,000
– –
CFIVW
39
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$74K ﹤0.01%
99,999
– –
HGASW
40
DELISTED
Global Gas Corporation Warrant
HGASW
$73K ﹤0.01%
149,999
– –
NXU.WS
41
DELISTED
Novus Capital Corporation II Redeemable warrants, each whole warrant exercisable for shares of Class
NXU.WS
$62K ﹤0.01%
49,999
– –
BNZIW icon
42
Banzai International Warrant
BNZIW
$167K
$56K ﹤0.01%
92,499
– –
SPAQ.WS
43
DELISTED
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
$54K ﹤0.01%
37,499
– –
PAQCW
44
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
$40K ﹤0.01%
74,999
– –
DLCAW
45
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$37K ﹤0.01%
60,000
– –
BIOTW
46
DELISTED
Biotech Acquisition Company Warrant
BIOTW
$33K ﹤0.01%
50,000
– –
FACA.WS
47
DELISTED
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
$29K ﹤0.01%
24,989
-10
-0% -$11
SHACW
48
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
$28K ﹤0.01%
50,000
– –
HCCCW
49
DELISTED
Healthcare Capital Corp. Warrant
HCCCW
$24K ﹤0.01%
50,000
– –
FCAX.WS
50
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$23K ﹤0.01%
29,999
– –
1
2
3

Similar funds

KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
HPCM
Hein Park Capital Management New York $61.3M AUM 14.47% 1-Year Est. Return
TCDRS
Texas County & District Retirement System Austin, Texas $60.8M AUM 29.03% 1-Year Est. Return
ACM
AREX Capital Management New York $60.5M AUM 45.91% 1-Year Est. Return
CMANY
Capital Management Associates (New York) New York $60.2M AUM 58.47% 1-Year Est. Return
NI
NCP Inc La Quinta, California $60.1M AUM 39.78% 1-Year Est. Return
GC
Greencape Capital Melbourne, Australia $59.9M AUM 23.92% 1-Year Est. Return
BGPJL
Bregal General Partner Jersey Ltd St. Helier, Jersey $62.3M AUM

Centerbridge Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Centerbridge Partners held 60 positions worth $1.75B, up 105% from $856M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Centerbridge Partners deployed $847M of net new capital in Q4 2021, opening 4 new positions and adding to 3 existing holdings. Its largest new stake was Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock: 66,207,182 shares worth $555M.

By sector, the portfolio is most concentrated in Real Estate at 15% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Community Health Systems, an estimated $4.45M trimmed.

  • Centerbridge Partners's largest Q4 2021 buy was Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock: 66,207,182 shares worth $555M.
  • Centerbridge Partners added most to Cedar Fair in Q4 2021, an estimated $73.4M increase.
  • Centerbridge Partners's biggest Q4 2021 reduction was Community Health Systems, cutting an estimated $4.45M.
  • Centerbridge Partners fully exited Spartan Acquisition Corp. III in Q4 2021, selling an estimated $1.48M.
  • Centerbridge Partners's ten largest holdings make up 94% of its $1.75B portfolio in Q4 2021.
  • Centerbridge Partners opened 4 new positions and closed 2 in Q4 2021.
  • Centerbridge Partners's portfolio value rose 105% quarter-over-quarter to $1.75B.

Based on Centerbridge Partners's 13F filing for Q4 2021, filed 14 Feb 2022.